保留比率的肺功能减损：COPD防控的重点
Preserved Ratio Impaired Spirometry: A Focus for the Prevention and Control of COPD
摘要: 慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease, COPD)作为常见的慢性气道炎症疾病之一，显著降低了患者的生活质量。FEV1/FVC < 70%作为COPD诊断标准存在一定争议，很多患者具有慢阻肺症状，并且CT显示有气道炎症和肺部损伤，但肺功能检测结果为健康状态。保留比率的肺功能减损(Preserved Ratio Impaired Spirometry, PRISm)作为COPD重要的表型之一及COPD发生、发展的高危人群，应力争做到早期识别、规范治疗、注重随访，这将是未来COPD防控的重点。本文将对PRISm的患病率，危险因素，临床特点，发病机制及诊疗方案做一综述。
Abstract: Chronic obstructive pulmonary disease is a common chronic inflammatory airway disease that significantly reduces the quality of life of patients. The diagnostic criterion for COPD, FEV1/FVC < 70%, is controversial. Many patients with symptoms of COPD and CT scans showing airway inflammation and lung damage have pulmonary function tests that indicate a healthy state. As one of the most significant phenotypes of COPD and a highrisk group for the occurrence and development of COPD, preserved ratio impaired spirometry (PRISm) should be identified and treated in a standardized manner, with regular followup, in order to facilitate the prevention and control of COPD in the future. This article will review the prevalence, risk factors, clinical characteristics, pathogenesis and treatment options of PRISm.
文章引用：康秀荷, 曲仪庆. 保留比率的肺功能减损：COPD防控的重点[J]. 临床医学进展, 2024, 14(6): 947-952. https://doi.org/10.12677/acm.2024.1461865

参考文献

[1] Agustí, A., Celli, B.R., Criner, G.J., Halpin, D., Anzueto, A., Barnes, P., et al. (2023) Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. European Respiratory Journal, 61, 2300239. [Google Scholar] [CrossRef] [PubMed]
[2] Guerra, S., Sherrill, D.L., Venker, C., Ceccato, C.M., Halonen, M. and Martinez, F.D. (2010) Morbidity and Mortality Associated with the Restrictive Spirometric Pattern: A Longitudinal Study. Thorax, 65, 499-504. [Google Scholar] [CrossRef] [PubMed]
[3] Kugler, W., Enssle, J., Hentze, M.W. and Kulozik, A.E. (1995) Nuclear Degradation of Nonsense Mutated Β-Globin Mrna: A Post-Transcriptional Mechanism to Protect Heterozygotes from Severe Clinical Manifestations of β-Thalassemia? Nucleic Acids Research, 23, 413-418. [Google Scholar] [CrossRef] [PubMed]
[4] Tokano, Y., Miyake, S., Kayagaki, N., Nozawa, K., Morimoto, S., Azuma, M., et al. (1996) Soluble Fas Molecule in the Serum of Patients with Systemic Lupus Erythematosus. Journal of Clinical Immunology, 16, 261-265. [Google Scholar] [CrossRef] [PubMed]
[5] Littleton, S.W. and Tulaimat, A. (2017) The Effects of Obesity on Lung Volumes and Oxygenation. Respiratory Medicine, 124, 15-20. [Google Scholar] [CrossRef] [PubMed]
[6] Leone, N., Courbon, D., Thomas, F., Bean, K., Jégo, B., Leynaert, B., et al. (2009) Lung Function Impairment and Metabolic Syndrome. American Journal of Respiratory and Critical Care Medicine, 179, 509-516. [Google Scholar] [CrossRef] [PubMed]
[7] van Westing, A.C., Ochoa-Rosales, C., van der Burgh, A.C., Chaker, L., Geleijnse, J.M., Hoorn, E.J., et al. (2023) Association of Habitual Coffee Consumption and Kidney Function: A Prospective Analysis in the Rotterdam Study. Clinical Nutrition, 42, 83-92. [Google Scholar] [CrossRef] [PubMed]
[8] Higbee, D.H., Granell, R., Davey Smith, G. and Dodd, J.W. (2022) Prevalence, Risk Factors, and Clinical Implications of Preserved Ratio Impaired Spirometry: A UK Biobank Cohort Analysis. The Lancet Respiratory Medicine, 10, 149-157. [Google Scholar] [CrossRef] [PubMed]
[9] Park, H.J., Byun, M.K., Rhee, C.K., Kim, K., Kim, H.J. and Yoo, K. (2018) Significant Predictors of Medically Diagnosed Chronic Obstructive Pulmonary Disease in Patients with Preserved Ratio Impaired Spirometry: A 3-Year Cohort Study. Respiratory Research, 19, Article No. 185. [Google Scholar] [CrossRef] [PubMed]
[10] Wei, X., Ding, Q., Yu, N., Mi, J., Ren, J., Li, J., et al. (2018) Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm). Lung, 196, 649-658. [Google Scholar] [CrossRef] [PubMed]
[11] Wan, E.S., Balte, P., Schwartz, J.E., Bhatt, S.P., Cassano, P.A., Couper, D., et al. (2021) Association between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults. JAMA, 326, 2287-2298. [Google Scholar] [CrossRef] [PubMed]
[12] Kim, J., Lee, C., Lee, H.Y. and Kim, H. (2021) Association between Comorbidities and Preserved Ratio Impaired Spirometry: Using the Korean National Health and Nutrition Examination Survey IV-VI. Respiration, 101, 25-33. [Google Scholar] [CrossRef] [PubMed]
[13] Washio, Y., Sakata, S., Fukuyama, S., Honda, T., Kan-o, K., Shibata, M., et al. (2022) Risks of Mortality and Airflow Limitation in Japanese Individuals with Preserved Ratio Impaired Spirometry. American Journal of Respiratory and Critical Care Medicine, 206, 563-572. [Google Scholar] [CrossRef] [PubMed]
[14] Perez-Padilla, R., Montes de Oca, M., Thirion-Romero, I., Wehrmeister, F.C., Lopez, M.V., Valdivia, G., et al. (2023) Trajectories of Spirometric Patterns, Obstructive and Prism, in a Population-Based Cohort in Latin America. International Journal of Chronic Obstructive Pulmonary Disease, 18, 1277-1285. [Google Scholar] [CrossRef] [PubMed]
[15] Wan, E.S., Hokanson, J.E., Regan, E.A., Young, K.A., Make, B.J., DeMeo, D.L., et al. (2022) Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry among Ever Smokers. Chest, 161, 651-661. [Google Scholar] [CrossRef] [PubMed]
[16] Fan, J., Fang, L., Cong, S., Zhang, Y., Jiang, X., Wang, N., et al. (2024) Potential Pre-COPD Indicators in Association with COPD Development and COPD Prediction Models in Chinese: A Prospective Cohort Study. The Lancet Regional Health—Western Pacific, 44, Article ID: 100984. [Google Scholar] [CrossRef] [PubMed]
[17] Kawatoko, K., Washio, Y., Ohara, T., Fukuyama, S., Honda, T., Hata, J., et al. (2023) Risks of Dementia in a General Japanese Older Population with Preserved Ratio Impaired Spirometry: The Hisayama Study. Journal of Epidemiology. [Google Scholar] [CrossRef] [PubMed]
[18] Chen, C., Zhang, S., Yang, T., Wang, C. and Han, G. (2023) Associations between Environmental Heavy Metals Exposure and Preserved Ratio Impaired Spirometry in the U.S. Adults. Environmental Science and Pollution Research, 30, 108274-108287. [Google Scholar] [CrossRef] [PubMed]
[19] Krishnan, S., Tan, W.C., Farias, R., et al. (2023) Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study. Chest, 164, 637-649.
[20] Kaaks, R., Christodoulou, E., Motsch, E., Katzke, V., Wielpütz, M.O., Kauczor, H., et al. (2022) Lung Function Impairment in the German Lung Cancer Screening Intervention Study (LUSI): Prevalence, Symptoms, and Associations with Lung Cancer Risk, Tumor Histology and All-Cause Mortality. Translational Lung Cancer Research, 11, 1896-1911. [Google Scholar] [CrossRef] [PubMed]
[21] Cortés-Ibáñez, F.O., Johnson, T., Mascalchi, M., Katzke, V., Delorme, S. and Kaaks, R. (2023) Serum-Based Biomarkers Associated with Lung Cancer Risk and Cause-Specific Mortality in the German Randomized Lung Cancer Screening Intervention (LUSI) Trial. Translational Lung Cancer Research, 12, 2460-2475. [Google Scholar] [CrossRef] [PubMed]
[22] Jin, Z. and Wang, G. (2024) Some Future Directions for Genome-Wide Association Studies of Preserved Ratio Impaired Spirometry. European Respiratory Journal, 63, Article ID: 2400142. [Google Scholar] [CrossRef] [PubMed]
[23] Phillips, D.B., James, M.D., Vincent, S.G., et al. (2024) Physiological Characterization of Preserved Ratio Impaired Spirometry in the CanCOLD Study: Implications for Exertional Dyspnea and Exercise Intolerance. American Journal of Respiratory and Critical Care Medicine.
[24] Wan, E.S., Fortis, S., Regan, E.A., et al. (2018) Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study. American Journal of Respiratory and Critical Care Medicine, 198, 1397-1405.
[25] Lu, J., Ge, H., Qi, L., Zhang, S., Yang, Y., Huang, X., et al. (2022) Subtyping Preserved Ratio Impaired Spirometry (prism) by Using Quantitative HRCT Imaging Characteristics. Respiratory Research, 23, Article No. 309. [Google Scholar] [CrossRef] [PubMed]
[26] Wan, E.S., Castaldi, P.J., Cho, M.H., Hokanson, J.E., Regan, E.A., Make, B.J., et al. (2014) Epidemiology, Genetics, and Subtyping of Preserved Ratio Impaired Spirometry (PRISm) in Copdgene. Respiratory Research, 15, Article No. 89. [Google Scholar] [CrossRef] [PubMed]
[27] He, D., Yan, M., Zhou, Y., et al. (2023) Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence from a Prospective Cohort Study. Chest, 165, 573-582.
[28] Im, Y., Park, H.Y., Lee, J., Kim, H., Yoo, H., Kang, M., et al. (2023) Impact of Preserved Ratio Impaired Spirometry on Coronary Artery Calcium Score Progression: A Longitudinal Cohort Study. ERJ Open Research, 10, 00819-2023. [Google Scholar] [CrossRef] [PubMed]
[29] Xiao, T., Wijnant, S.R.A., van der Velpen, I., Terzikhan, N., Lahousse, L., Ikram, M.K., et al. (2022) Lung Function Impairment in Relation to Cognition and Vascular Brain Lesions: The Rotterdam Study. Journal of Neurology, 269, 4141-4153. [Google Scholar] [CrossRef] [PubMed]
[30] Alison, J.A., McKeough, Z.J., Johnston, K., McNamara, R.J., Spencer, L.M., Jenkins, S.C., et al. (2017) Australian and new zealand pulmonary rehabilitation guidelines. Respirology, 22, 800-819. [Google Scholar] [CrossRef] [PubMed]
[31] Schrijver, J., Lenferink, A., Brusse-Keizer, M., Zwerink, M., van der Valk, P.D., van der Palen, J., et al. (2022) Self-management Interventions for People with Chronic Obstructive Pulmonary Disease. Cochrane Database of Systematic Reviews, No. 1, CD002990. [Google Scholar] [CrossRef] [PubMed]
[32] Warburton, D., Gauldie, J., Bellusci, S. and Shi, W. (2006) Lung Development and Susceptibility to Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society, 3, 668-672. [Google Scholar] [CrossRef] [PubMed]
[33] Sin, D.D. (2022) Rethincking COPD—Bronchodilators for Symptomatic Tobacco-Exposed Persons with Preserved Lung Function? New England Journal of Medicine, 387, 1230-1231. [Google Scholar] [CrossRef] [PubMed]
[34] Willemse, B.W.M., Postma, D.S., Timens, W. and ten Hacken, N.H.T. (2004) The Impact of Smoking Cessation on Respiratory Symptoms, Lung Function, Airway Hyperresponsiveness and Inflammation. European Respiratory Journal, 23, 464-476. [Google Scholar] [CrossRef] [PubMed]
[35] Yang, I.A., Jenkins, C.R. and Salvi, S.S. (2022) Chronic Obstructive Pulmonary Disease in Never-Smokers: Risk Factors, Pathogenesis, and Implications for Prevention and Treatment. The Lancet Respiratory Medicine, 10, 497-511. [Google Scholar] [CrossRef] [PubMed]
[36] Sin, D.D., Doiron, D., Agusti, A., Anzueto, A., Barnes, P.J., Celli, B.R., et al. (2023) Air Pollution and COPD: GOLD 2023 Committee Report. European Respiratory Journal, 61, Article ID: 2202469. [Google Scholar] [CrossRef] [PubMed]
[37] Poole, P., Chacko, E.E., Wood-Baker, R. and Cates, C.J. (2006) Influenza Vaccine for Patients with Chronic Obstructive Pulmonary Disease. Cochrane Database of Systematic Reviews, No. 1, CD002733. [Google Scholar] [CrossRef] [PubMed]

为你推荐